Parenchymal-sparing hepatectomy for deep-placed colorectal liver metastases

Surgery (United States)

Volumn 160, Issue 5, 2016, Pages 1256-1263

  Matsuki, Ryota ^a   Mise, Yoshihiro ^a   Saiura, Akio ^a   Inoue, Yosuke ^a   Ishizawa, Takeaki ^a   Takahashi, Yu ^a  

^a CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLIZATION; CANCER SURGERY; CLINICAL ASSESSMENT; COLORECTAL LIVER METASTASIS; CONTROLLED STUDY; FEMALE; HUMAN; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; OPERATIVE BLOOD LOSS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENCE FREE SURVIVAL; TREATMENT INDICATION; CANCER STAGING; COHORT ANALYSIS; COLORECTAL NEOPLASMS; COMPARATIVE STUDY; DIAGNOSTIC IMAGING; DISEASE FREE SURVIVAL; FOLLOW UP; IMAGE PROCESSING; KAPLAN MEIER METHOD; LAPAROTOMY; LIVER NEOPLASMS; MIDDLE AGED; MINIMALLY INVASIVE SURGERY; MORTALITY; PARENCHYMA; PATHOLOGY; PROCEDURES; RETROSPECTIVE STUDY; RISK ASSESSMENT; SECONDARY; SURVIVAL ANALYSIS; TIME FACTOR; TREATMENT OUTCOME; TUMOR INVASION; X-RAY COMPUTED TOMOGRAPHY;

AGED; COHORT STUDIES; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; KAPLAN-MEIER ESTIMATE; LAPAROTOMY; LIVER NEOPLASMS; MALE; MIDDLE AGED; MINIMALLY INVASIVE SURGICAL PROCEDURES; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OPERATIVE TIME; PARENCHYMAL TISSUE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84994314249     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2016.06.041     Document Type: Article

References (33)

1. 1 Kopetz, S., Chang, G.J., Overman, M.J., Eng, C., Sargent, D.J., Larson, D.W., et al. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol 27 (2009), 3677–3683.
2. 2 Brouquet, A., Abdalla, E.K., Kopetz, S., Garrett, C.R., Overman, M.J., Eng, C., et al. High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome. J Clin Oncol 29 (2011), 1083–1090.
3. 3 Shindoh, J., Tzeng, C.W., Aloia, T.A., Curley, S.A., Huang, S.Y., Mahvash, A., et al. Safety and efficacy of portal vein embolization before planned major or extended hepatectomy: an institutional experience of 358 patients. J Gastrointest Surg 18 (2014), 45–51.
4. 4 Abulkhir, A., Limongelli, P., Healey, A.J., Damrah, O., Tait, P., Jackson, J., et al. Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg 247 (2008), 49–57.
5. 5 Evrard, S., Poston, G., Kissmeyer-Nielsen, P., Diallo, A., Desolneux, G., Brouste, V., et al. Combined ablation and resection (CARe) as an effective parenchymal sparing treatment for extensive colorectal liver metastases. PLoS One, 9, 2014, e114404.
6. 6 Lee, H., Heo, J.S., Cho, Y.B., Yun, S.H., Kim, H.C., Lee, W.Y., et al. Hepatectomy vs radiofrequency ablation for colorectal liver metastasis: a propensity score analysis. World J Gastroenterol 21 (2015), 3300–3307.
7. 7 Tropea, A., Biondi, A., Corsaro, A., Donati, M., Basile, F., Gruttadauria, S., Combined microwave thermal ablation and liver resection for single step treatment of otherwise unresectable colorectal liver metastases; a monoistitutional experiences. Eur Rev Med Pharmacol Sci 18 (2014), 6–10.
8. 8 Cirocchi, R., Trastulli, S., Boselli, C., Montedori, A., Cavaliere, D., Parisi, A., et al. Radiofrequency ablation in the treatment of liver metastases from colorectal cancer. Cochrane Database Syst Rev, 6, 2012, CD006317.
9. 9 Gold, J.S., Are, C., Kornprat, P., Jarnagin, W.R., Gonen, M., Fong, Y., et al. Increased use of parenchymal-sparing surgery for bilateral liver metastases from colorectal cancer is associated with improved mortality without change in oncologic outcome: trends in treatment over time in 440 patients. Ann Surg 247 (2008), 109–117.
10. 10 Kokudo, N., Tada, K., Seki, M., Ohta, H., Azekura, K., Ueno, M., et al. Anatomical major resection versus nonanatomical limited resection for liver metastases from colorectal carcinoma. Am J Surg 181 (2001), 153–159.
11. 11 Lalmahomed, Z.S., Ayez, N., van der Pool, A.E., Verheij, J., IJzermans, J.N., Verhoef, C., Anatomical versus nonanatomical resection of colorectal liver metastases: is there a difference in surgical and oncological outcome?. World J Surg 35 (2011), 656–661.
12. 12 Lim, C., Ishizawa, T., Miyata, A., Mise, Y., Sakamoto, Y., Hasegawa, K., et al. Surgical indications and procedures for resection of hepatic malignancies confined to segment VII. Ann Surg 263 (2016), 529–537.
13. 13 Torzilli, G., Donadon, M., Marconi, M., Botea, F., Palmisano, A., Del Fabbro, D., et al. Systematic extended right posterior sectionectomy: a safe and effective alternative to right hepatectomy. Ann Surg 247 (2008), 603–611.
14. 14 Torzilli, G., Procopio, F., Botea, F., Marconi, M., Del Fabbro, D., Donadon, M., et al. One-stage ultrasonographically guided hepatectomy for multiple bilobar colorectal metastases: a feasible and effective alternative to the 2-stage approach. Surgery 146 (2009), 60–71.
15. 15 Urbani, L., Masi, G., Puccini, M., Colombatto, P., Vivaldi, C., Balestri, R., et al. Minor-but-complex liver resection: an alternative to major resections for colorectal liver metastases involving the hepato-caval confluence. Medicine, 94, 2015, e1188.
16. 16 Mise, Y., Aloia, T.A., Brudvik, K.W., Schwarz, L., Vauthey, J.N., Conrad, C., Parenchymal-sparing hepatectomy in colorectal liver metastasis improves salvageability and survival. Ann Surg 263 (2016), 146–152.
17. 17 Makuuchi, M., Kosuge, T., Takayama, T., Yamazaki, S., Kakazu, T., Miyagawa, S., et al. Surgery for small liver cancers. Semin Surg Oncol 9 (1993), 298–304.
18. 18 Arita, J., Ono, Y., Takahashi, M., Inoue, Y., Takahashi, Y., Saiura, A., Usefulness of contrast-enhanced intraoperative ultrasound in identifying disappearing liver metastases from colorectal carcinoma after chemotherapy. Ann Surg Oncol 21:Suppl 3 (2014), 390–397.
19. 19 Dindo, D., Demartines, N., Clavien, P.A., Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240 (2004), 205–213.
20. 20 Ikeda, Y., Matsumata, T., Takenaka, K., Sasaki, O., Soejima, K., Sugimachi, K., Preliminary report of tumor metastasis during liver regeneration after hepatic resection in rats. Eur J Surg Oncol 21 (1995), 188–190.
21. 21 Jiang, W., Hiscox, S., Matsumoto, K., Nakamura, T., Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer. Crit Rev Oncol Hematol 29 (1999), 209–248.
22. 22 Lim, C., Cauchy, F., Azoulay, D., Farges, O., Ronot, M., Pocard, M., Tumour progression and liver regeneration–insights from animal models. Nat Rev Gastroenterol Hepatol 10 (2013), 452–462.
23. 23 Lukomska, B., Dluzniewska, J., Polanski, J., Zajac, L., Expression of growth factors in colorectal carcinoma liver metastatic patients after partial hepatectomy: implications for a functional role in cell proliferation during liver regeneration. Comp Hepatol, 3(Suppl 1), 2004, S52.
24. 24 Mizutani, J., Hiraoka, T., Yamashita, R., Miyauchi, Y., Promotion of hepatic metastases by liver resection in the rat. Br J Cancer 65 (1992), 794–797.
25. 25 Tanaka, K., Shimada, H., Matsumoto, C., Matsuo, K., Takeda, K., Nagano, Y., et al. Impact of the degree of liver resection on survival for patients with multiple liver metastases from colorectal cancer. World J Surg 32 (2008), 2057–2069.
26. 26 Yoon, S.S., Kim, S.H., Gonen, M., Heffernan, N.M., Detwiller, K.Y., Jarnagin, W.R., et al. Profile of plasma angiogenic factors before and after hepatectomy for colorectal cancer liver metastases. Ann Surg Oncol 13 (2006), 353–362.
27. 27 Matsumura, M., Mise, Y., Saiura, A., Inoue, Y., Ishizawa, T., Ichida, H., et al. Parenchymal-sparing hepatectomy does not increase intrahepatic recurrence in patients with advanced colorectal liver metastases. Ann Surg Oncol, 2016 [Epub ahead of print].
28. 28 Chiappa, A., Bertani, E., Zbar, A.P., Foschi, D., Fazio, N., Zampino, M., et al. Optimizing treatment of hepatic metastases from colorectal cancer: Resection or resection plus ablation?. Int J Oncol 48 (2016), 1280–1289.
29. 29 Tanis, E., Nordlinger, B., Mauer, M., Sorbye, H., van Coevorden, F., Gruenberger, T., et al. Local recurrence rates after radiofrequency ablation or resection of colorectal liver metastases. Analysis of the European Organisation for Research and Treatment of Cancer #40004 and #40983. Eur J Cancer 50 (2014), 912–919.
30. 30 Gillams, A., Goldberg, N., Ahmed, M., Bale, R., Breen, D., Callstrom, M., et al. Thermal ablation of colorectal liver metastases: a position paper by an international panel of ablation experts, The Interventional Oncology Sans Frontieres meeting 2013. Eur Radiol 25 (2015), 3438–3454.
31. 31 Brouquet, A., Vauthey, J.N., Badgwell, B.D., Loyer, E.M., Kaur, H., Curley, S.A., et al. Hepatectomy for recurrent colorectal liver metastases after radiofrequency ablation. Br J Surg 98 (2011), 1003–1009.
32. 32 Yamashita, S., Aoki, T., Inoue, Y., Kaneko, J., Sakamoto, Y., Sugawara, Y., et al. Outcome of salvage hepatic resection for recurrent hepatocellular carcinoma after radiofrequency ablation therapy. Surgery 157 (2015), 463–472.
33. 33 Nordlinger, B., Sorbye, H., Glimelius, B., Poston, G.J., Schlag, P.M., Rougier, P., et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 371 (2008), 1007–1016.